Denosumab
Denosumab
About this item
Full title
Denosumab
Author / Creator
Publisher
Auckland: Springer Nature B.V
Journal title
Drugs (New York, N.Y.), 2011-05, Vol.71 (8), p.1059
Language
English
Formats
Publication information
Publisher
Auckland: Springer Nature B.V
More information
Scope and Contents
Contents
Denosumab, a fully human monoclonal antibody, binds to the receptor activator of nuclear factor-κB ligand (RANKL) and thereby inhibits RANKL-mediated bone resorption. In various individual countries, subcutaneous denosumab is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumours (featured indica...
Alternative Titles
Full title
Denosumab
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_871572475
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_871572475
Other Identifiers
ISSN
0012-6667
E-ISSN
1179-1950
DOI
10.2165/11207370-000000000-00000
How to access this item
Log in as a Library member
